معرفی
Francesca Fiorentino is a Research Professor with a focus on clinical trials and medical statistics, contributing to research in oncology, dermatology, and emergency medicine. She holds academic qualifications from Imperial College London (BSc and MSc in Physics) and University College London (DSc in Mathematical Modelling). Her research addresses UN Sustainable Development Goals related to health and well-being, emphasizing evidence-based interventions. She leads and co-investigates multiple NIHR-funded projects, including studies on EMS staff safety, pulmonary rehabilitation, and incontinence-associated dermatitis prevention. Recent work includes randomized controlled trials on prostate cancer screening (IP1-PROSTAGRAM) and obesity treatment (EMBIO trial). Her research interests span clinical trial methodology, biomarker development, and healthcare innovation.
Education:
- Master in Science (Theoretical Physics), Imperial College London
- Bachelor of Science (Physics), Imperial College London
- Doctor of Science (Mathematical Modelling), University College London
Research Interests:
- Design and analysis of clinical trials
- Prostate cancer screening and diagnostics
- Prevention of healthcare-associated conditions (e.g., incontinence dermatitis)
- Biomarker development for cancer detection
- Healthcare policy and implementation science
Grants and Projects:
- Primary Investigator: Asp-PSC (Cancer Research UK, 2023)
- Co-Investigator: CORE Study (NIHR, 2024–2026), Veteran PETT (NIHR, 2024–2028), SELF-BREATHE (NIHR, 2023–2028)
Labs/Teams: Collaborations include Imperial College London, NIHR, and international partners in oncology, dermatology, and emergency medicine research.
